US Broker Ratings

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 45% Upside Potential in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company headquartered in Zug, Switzerland, is capturing investor attention with its innovative approach to treating inflammatory skin and joint diseases. Despite its relatively..

Sotera Health Company (SHC) Stock Analysis: A 29% Upside Potential Awaits Healthcare Investors

Sotera Health Company (NASDAQ: SHC), a pivotal player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to the medical and pharmaceutical..

Alvotech (ALVO) Stock Analysis: Unpacking the 97% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based powerhouse in the healthcare sector specializing in biosimilar medicines, is catching the eye of investors with its impressive growth trajectory and significant upside potential. With..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a Potential 57.88% Upside in Biotech Innovation

Arcellx, Inc. (ACLX) is making waves in the healthcare sector, particularly within the biotechnology industry, as it continues to develop groundbreaking immunotherapies aimed at tackling cancer and other incurable diseases...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 27% Upside Potential with a Solid Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, has caught the attention of investors with its diverse product offerings and potential upside. As the company navigates..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Robust Growth and Promising Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is capturing investor attention with its strategic focus on developing and commercializing treatments for central nervous system (CNS) disorders and rare diseases. With a market..

Haemonetics Corporation (HAE) Stock Analysis: Evaluating a 21.17% Potential Upside in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a key player in the medical devices industry, offers a compelling investment opportunity within the healthcare sector. With a market capitalization of $3.67 billion, Haemonetics stands..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating Biotech’s Growth Frontier

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has established itself as a noteworthy player in the biotechnology sector, with a specific focus on developing therapies for rare diseases and certain types of..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Exploring a 76% Potential Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector might want to pay close attention to Lantheus Holdings, Inc. (NASDAQ: LNTH). With a robust portfolio of diagnostic and therapeutic products..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 32% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of genetic medicines. Headquartered in Pittsburgh, Pennsylvania, this..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Healthcare Game Changer with a 5.93% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. As a leader in the medical devices industry, iRhythm is reshaping..

Bruker Corporation (BRKR) Stock Analysis: Navigating a 44% Potential Upside Amidst Market Volatility

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its intriguing financial metrics. As of the latest..

Waystar Holding Corp. (WAY) Stock Analysis: A 41.57% Potential Upside and Strong Buy Ratings Propel Healthcare IT Specialist

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare IT sector, having carved out a niche with its innovative cloud-based payment solutions. With a market cap of $6.2..

HealthEquity, Inc. (HQY) Stock Analysis: Promising 34% Upside Potential Sparks Investor Interest

In the dynamic landscape of healthcare services, HealthEquity, Inc. (NASDAQ: HQY) emerges as a compelling investment opportunity, particularly for those eyeing robust growth potential. As a leader in the health..

Verona Pharma plc (VRNA) Stock Analysis: Exploring the 0.99% Potential Upside in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a UK-based biopharmaceutical powerhouse, has become a focal point of interest in the healthcare sector, particularly within the biotechnology industry. With its current market capitalization..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 50% Upside Potential for Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is currently making waves in the investment community with its robust pipeline of innovative treatments and an enticing..

Telix Pharmaceuticals Limited (TLX): Investor Outlook and Potential 73.33% Upside

Telix Pharmaceuticals Limited (TLX), a dynamic player in the biotechnology sector, is making waves with its innovative approach to therapeutic and diagnostic radiopharmaceuticals. With a market capitalization of $4.37 billion,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Biotech Innovator Poised for 30% Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a standout in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of transformative medicines targeting genetic diseases and cancers. As..

Glaukos Corporation (GKOS) Investor Outlook: A 42.85% Upside Amidst Promising Growth in Medical Devices

Glaukos Corporation (NYSE: GKOS), a pioneering player in the healthcare sector, is captivating investor interest with its robust growth prospects and a substantial potential upside of 42.85%. As a leading..

Bausch + Lomb (BLCO) Stock Analysis: Exploring a Potential 11% Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector with a rich history dating back to 1853, presents a compelling investment case for those looking to diversify..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds